Healthcare Equipment and Supplies
Company Overview of Xeltis AG
Xeltis AG is a medical device company that develops bioabsorbable heart valves and blood vessels. Its technology enables a therapeutic approach in cardiovascular and regenerative medicine called Endogenous Tissue Restoration (ETR) via synthetic biodegradable heart valves and blood vessels designed to harness the body's innate healing process to enable natural restoration of complex anatomical parts within the body. The company was founded in 2006 and is based in Zurich, Switzerland with R&D and manufacturing facilities in Eindhoven, the Netherlands.
Founded in 2006
41 44 269 79 79
41 44 269 79 78
Key Executives for Xeltis AG
Xeltis AG Key Developments
Similar Private Companies By Industry
|99 Technologies S.A.||Europe|
|ABC Orthodontics SA||Europe|
|Acrostak (Schweiz) AG||Europe|
|ACUTRONIC Medical Systems AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xeltis AG, please visit www.xeltis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.